
































and	 the	 molecules	 responsible	 are	 still	 controversial.	 Thus,	 the	 aim	 of	 this	 study	 was	 to
evaluate	 the	effect	of	 leaves	methanol	extract	of	Tecoma	stans	 and	some	of	 its	 fractions	on
starch	 tolerance	 in	 healthy	 rats,	 in	 vitro	 inhibition	 of	 α‐amylase,	 and	 their	 effects	 of	 sub‐
chronic	administration	of	glucose,	 lipid	pattern,	kidney	and	 liver	 functions	and	antioxidant
status	 in	 streptozotocin	 (STZ)	 induced	 diabetic	 rats.	 In	 starch	 tolerance	 experiment,	 both
ethyl	acetate	and	crude	flavonoids	fractions	decreased	glycemic	peak	values	in	healthy	rats
to	 extent	 similar	 to	 that	 of	 acarbose.	 In	 STZ	 sub‐chronic	 experiment	 all	 preparations	 of
Tecoma	 stans	 significantly	 decreased	 fasting	 glucose	 with	 variable	 degrees.	 The	 results
indicated	that	the	crude	methanol	extract	had	the	most	antidiabetic	potential	followed	by	the
methylene	 chloride	 rich	 alkaloid	 fraction	while	 the	 crude	 flavonoids	 fraction	 achieved	 the
lowest	 effect.	 All	Tecoma	 stans	different	 preparations	 have	 positive	 effects	 on	 serum	 lipid
pattern,	 kidney	 and	 liver	 function	 parameters,	 in	 addition	 to	 the	 antioxidant	 parameters
(MDA	and	GSH)	in	liver	tissues.	In	conclusion,	the	present	study	suggested	that	the	alkaloids
synergistically	 act	 as	 antidiabetic	 agent	 with	 other	 bioactive	 compounds	 of	 Tecoma	 stans













Diabetes	mellitus	 is	 an	 endocrine	 disorder	 which	mainly	
raises	 glucose	 level	 in	 the	 blood	 stream	 due	 to	 the	 defect	 in	
insulin	 secretion,	 insulin	 action	 or	 both	 [1].	 In	 addition,	 it	 is	
associated	with	long	term	damage	such	as	malfunction	of	eyes,	
kidneys,	 nerves,	 heart	 and	 blood	 vessels.	 In	 another	 word,	
diabetes	 is	 associated	 with	 health	 complications,	 including	
renal	 failure,	 sexual	 dysfunction,	 heart	 disease,	 stroke	 and	
blindness.	
Tecoma	 stans	 (L.)	 (Bignoniaceae)	 is	 used	 in	 traditional	
medicine	 for	 treatment	 of	 diabetes	 and	 urinary	 disorder	
control	 [2].	 Hypoglycemic	 responses	 of	 that	 plant	 have	 been	
reported	 by	 many	 authors	 [3‐5].	 In	 the	 past,	 it	 had	 been	
thought	 that,	 tecomine	 and	 tecostatine	 alkaloids	 were	
responsible	 for	 the	 antidiabetic	 potential	 of	 the	plant	 [6].	On	
the	 contrary,	 four	 purified	 alkaloids	 from	 Tecoma	 stans	 (T.	
stans)	 including	 tecomine	 and	 tecostanine	 did	 not	 decrease	
glucose	 level	 of	 diabetic	 db/db	 mice	 [7,8].	 In	 a	 more	 recent	
paper,	 Tecoma	 aqueous	 extract	 exhibited	 their	 antidiabetic	
action	 through	 the	 inhibition	 of	 intestinal	 α‐glucosidase	
without	 decreasing	 fasting	 glucose	 in	 STZ‐induced	 diabetic	
rats	[9].	They	showed	that	phenolic	compounds	present	in	the	
tecoma	 aqueous	 extract	 are	 responsible	 for	 these	 positive	
activities.		
Now,	 the	 antidiabetic	 activity	 of	 Tecoma	 stans	 is	 well	
postulated	 but	 its	 mode	 of	 action	 and	 the	 molecules	
responsible	 is	 still	 controversial.	 So,	 searching	 for	 the	 anti‐





and	 other	 fractions	 of	 successive	 extraction	 of	 methanolic	
extract	 and	 to	 examine	 them	 as	 follows:	 the	 effect	 on	 the	
starch	 hydrolysis	 in	 healthy	 rats,	 in	 vitro	 inhibition	 of	 α‐
amylase,	 and	 the	 effects	 of	 sub‐chronic	 doses	 of	 methanolic	
extract	and	their	fractions	on	glucose,	lipid	pattern,	kidney	and	

















in	 methanol	 overnight	 [10].	 The	 extraction	 process	 was	
repeated	twice,	and	then	the	combined	methanolic	extract	was	





Methanolic	 extract	 of	 T.	 stans	 suspended	 in	 water	 (in	 a	
ratio	 of	 1:4)	 and	 extracted	 using	 four	 solvents	 increasing	 in	
their	 polarity	 i.e.	 petroleum	 ether,	 methylene	 chloride,	 ethyl	
acetate	 and	 butanol.	 Then	 the	 solvent	 of	 each	 fraction	 was	







several	 steps	 the	 crude	 flavonoids	 were	 extracted	 in	 H2O	





Preliminary	 phytochemical	 analysis	 was	 carried	 out	 on	
crude	methanolic	extract	(as	mother	liquor)	of	T.	stans	and	its	
fractions:	 methylene	 chloride,	 ethyl	 acetate,	 butanol	 and	
flavonoids	 fractions	 to	 detect	 the	 presence	 of	 terpenes,	
saponins,	 alkaloids,	 flavonoids,	 glycosides	 and	 tannins.	 All	





The	 total	 flavonoids	 content	 of	 the	 mother	 methanolic	
extract	 of	T.	 stans	 and	 their	 resultant	 fractions	by	 successive	
extraction	 or	 crude	 flavonoid	 extraction	 were	 estimated	 by	
aluminium	 chloride	 colorimetric	method	 as	 described	 by	 Lin	




temperature,	 the	 absorbance	 of	 the	 developed	 color	 was	
measured	at	415	nm.	Quercetin	 (QE)	was	used	as	a	 standard	





The	 total	phenolics	of	 the	previously	mentioned	 fractions	
were	 determined	 according	 to	 the	 Folin‐Ciocalteu	method	 as	
described	by	Singleton	et	al.	 [14].	Gallic	acid	was	chosen	as	a	










HPLC	 chromatography	 was	 used	 for	 the	 detection	 and	
quantification	 of	 different	 flavonoids	 and	 polyphenols	 in	 the	
leaves	 of	 T.	 stans.	 HPLC	 analysis	 was	 conducted	 in	 The	







liquid	 chromatography	 equipped	 with	 diode	 array	 detector	
was	 used.	 Column	 temperature	 was	 set	 at	 35	 °C,	 gradient	
elution	was	employed	with	50	mM	H3PO4,	pH	=	2.5	 (solution	
A)	 and	 acetonitrile	 (solution	 B)	 as	 the	 mobile	 phase.	 All	
flavonoids	 were	 quantified	 using	 the	 external	 standard	








(RP‐HPLC)/diode	 array	 detection	 (DAD)	 (Hewlett	 Packard	
1050)	 with	 a	 guard	 column	 Alltima	 C18,	 5	 mm	 (Alltech).	 A	
gradient	 elution	 was	 employed	 using	 a	 solvent	 system	 of	 A	
(CH3COOH	2.5%),	B	 (CH3COOH,	8%)	and	C	 (acetonitrile).	The	
flow	 rate	 of	 the	 solvent	 was	 1	 mL/min	 and	 separation	 was	
performed	 at	 35	 °C.	 Phenolics	 were	 assayed	 by	 external	






TLC	 plate	 according	 to	 standard	 method	 described	 by	
Harborne	 [11].	 Rutin	 was	 used	 as	 a	 reference	 flavonoid.	
Different	mobile	phases	were	employed	in	the	screening	tests	






The	 plant	 methanolic	 extract	 (as	 mother	 liquor)	 and	 its	
three	solvent	fractions	plus	flavonoids	fraction	were	applied	to	
measure	 the	 anti	 α‐amylase	 activity	 using	 starch	 iodine	
method	 as	 described	 by	 Hussain	 et	 al.	 [17].	 Inhibition	 of	 α‐
amylase	activity	was	calculated	as	follows:	
	











Starch	 (2	 g/kg	 body	weight)	was	 administrated	 orally	 to	
healthy	 adapted	 rats	 after	 giving	 an	 oral	 dose	 of	 water,	
acarbose,	 methanolic	 extract,	 methylene	 chloride,	 ethyl	
acetate,	butanol	and	crude	flavonoids	fractions	as	250	mg/kg	
body	weight.	To	evaluate	in	vivo	inhibitory	activity	of	different	
fractions	 of	 T.	 stans	 on	 the	 hydrolysis	 of	 starch,	 blood	 was	





A	 number	 of	 60	 albino	 rats	 weighing	 (100‐150	 g)	 were	
kept	 7	 days	 for	 adaptation	 under	 laboratory	 conditions.	 All	







Compound	 Methanol	extract	 Methylene	chloride	fraction			 Ethyl	acetate	fraction	 Butanol	fraction	
Terpenes	 ++	 + ‐ ‐	
Saponins	 +	 + ++ +	
Alkaloids	 ++	 +++ ‐ ‐	
Flavonoids	 ++	 ++ +++ ++	
Glycosides	 ++	 ‐	 +	 +++	









Flavonoids	mg	as	quercetin	equivalents/g	fraction	 51.19	 39.21	 59.91	 45.75	 55.55	
Polyphenols	mg	as	gallic	acid	equivalents	(GAE)	/g	fraction	 230.3	 102.49	 279.41	 232.0	 264.7	
	
	
The	 other	 fifty	 three	 rats	 were	 fasted	 for	 24	 hours	 then	
injected	intraperitoneal	by	 freshly	prepared	streptozotocin	in	
0.1	M	 citrate	 buffer,	 pH	 =	 4.5	 at	 a	 dose	 of	 40	mg/kg	 b.w	 to	
induce	 diabetes	 mellitus	 [18].	 In	 order	 to	 stave	 off	 the	
hypoglycemic	 effect	 during	 the	 first	 day	 after	 streptozotocin	
injection,	 rats	 were	 given	 5%	 glucose	 solution	 orally	 as	
reported	by	Orhan	et	al.	[19].	After	72	hours	of	streptozotocin	
injection,	serum	glucose	levels	of	all	diabetic	rats	(fasted	for	18	
hours)	 were	 determined.	 Rats	 showed	 blood	 glucose	 levels	
over	 250	 mg/dL	 were	 considered	 as	 diabetic	 rats	 and	 were	
employed	 in	 the	 study.	 The	 diabetic	 rats	was	 then	 randomly	
divided	 into	 6	 groups	 (2‐7).	 Each	 group	 composed	 of	 7	 rats.	
Group	 2	 represented	 control	 diabetic	 rats,	 received	 normal	
diet	 for	28	days	without	any	 treatment.	Group	3	 represented	
diabetic	 rats,	 fed	 a	 normal	 diet	 for	 the	 same	 period	 with	
metformin	 hydrochloride	 powder	 (500	 mg/kg	 b.w.)	 as	 a	
reference	 drug.	 Groups	 4,	 5,	 6	 and	 7	 were	 diabetic	 rats	
received	 normal	 diet	 until	 the	 end	 of	 the	 experiment	 with	
methylene	chloride,	ethyl	acetate,	butanol	and	crude	flavonoid	
fractions,	 respectively	 as	 250	 mg/kg	 b.w.	 At	 the	 end	 of	 the	
experiment	blood	samples	were	taken	from	eyes	orbital	plexus	
and	centrifuged	without	anticoagulant	at	4000	rpm	for	20	min	
to	 separate	 serum,	 which	 kept	 frozen	 (‐20	 °C)	 till	 analysis.	
Then,	 the	 rats	 were	 fasted	 overnight,	 killed	 by	 decapitation	





Serum	 total	 cholesterol	 (TC)	 [20],	 triglycerides	 (TG)	 [21],	
high	density	lipoprotein	cholesterol	(HDL‐c)	[22],	glucose	[23],	
creatinine	[24],	uric	acid	[25,26]	and	alanine	aminotransferase	
(ALT)	 [27]	 were	 estimated	 using	 enzymatic	 kits	 (Spinreact	
company,	 Spain).	 Serum	 low	 density	 lipoprotein	 cholesterol	





Serum	 very	 low	 density	 lipoprotein	 cholesterol	 (VLDL‐c)	
was	 calculated	 according	 to	 Norbert	 [28]	 formula:	 VLDL‐c	 =	







Hepatic	 lipid	 peroxidation	 level	 was	 estimated	 using	
colorimetric	 reaction	 employ	 thiobarbituric	 acid‐positive	
reactant	 substances	 (TBARS)	 and	was	 expressed	 in	 terms	 of	
the	 malondialdehyde	 (MDA)	 concentration	 using	 1,1,3,3‐
tetraethoxy	 propane	 as	 a	 standard.	 Nanomoles	 of	 MDA	 per	
gram	 of	 tissue	 for	 the	 samples	 under	 investigation	 were	
measured	using	spectrophotometer	at	535	nm	[30].	
The	 hepatic	 reduced	 glutathione	 (GSH)	 level	 was	
measured	 at	 412	 nm	 using	 colorimetric	 reaction	 in	 the	
presence	of	 5,5'‐dithio‐bis‐2‐nitrobenzoic	 acid	 (DTNB).	Redu‐





All	 values	 were	 expressed	 as	 the	 mean±	 SD	 of	 seven	
animals	per	group.	Data	were	analyzed	using	one‐way	ANOVA	
followed	 by	 the	 post‐hoc	 Duncan	 multiple	 range	 test	 for	









crude	 methanolic	 extract	 depending	 on	 the	 ability	 of	 the	
compounds	 to	 dissolve	 in	 such	 solvent	 was	 produced	
petroleum	 ether	 (6.5%),	 CH2Cl2	 (5.5%),	 EtOAc	 (15.5%),	 n‐
BuOH	 (23.2%)	 fractions.	 Petroleum	 ether	 fraction	 was	
discarded	 as	 it	 represented	 hydrocarbons	 and	 other	 fatty	
materials.	On	the	other	hand,	the	extraction	percentage	of	the	
separately	 crude	 flavonoids	 extraction	 from	 the	 mother	
methanolic	extract	was	11.44	%.	
The	results	of	preliminary	phytochemical	screening	of	the	




ethyl	 acetate	 and	 butanol	 fractions.	 Alkaloids	 were	 only	
detected	 in	 methylene	 chloride	 fraction.	 The	 detected	





Flavonoids	 are	 a	 large	 group	 of	 the	 phenolic	 compounds	
consisting	 mainly	 of	 flavonols	 and	 anthocyanins.	 Phenolic	
compounds	can	prevent	body	cells	and	organs	from	injuries	by	
hydrogen	peroxide,	damage	by	lipid	peroxides	and	scavenging	
free	 radicals	 [34].	 The	 total	 flavonoids	 were	 determined	 in	
different	 solvent	extracts	as	mg	of	quercetin	per	gram	of	dry	
extract.	Total	flavonoids	content	in	Table	2	ranged	from	39.21	




acetate	 solvent	 fraction	 contained	 the	 highest	 amount	 of	
polyphenols	as	279.41	mg	gallic	acid	equivalents	(GAE)/g	dry	










Naringin	 21.4	 Chlorogenic acid 17.04	
Rutin	 112.7	 p‐Hydroxybenzoic	acid	 6.28	
Rosmarinic	acid	 27.1	 Caffeic	acid	 1.40	
Quercitrin	 16.6	 Vanillic	acid	 5.87	
Quercetin	 14.0	 Ferulic	acid	 31.38	
Kaempferol	 2.8 Isoferulic	acid 5.02	
Apigenin	 3.9 Ellagic acid 8.91	
Hesperetin	 7.97	 3,4,5‐Trimethoxy‐cinnamic	acid 21.56	
7‐OH‐flavone	 0.9 p‐Coumaric	acid 1.49	
Catechin	 10.74	 Cinnamic	acid 0.31	















Normal	 105.22	 117.76	 ‐11.91 127.8 ‐21.45 115.21	 ‐9.49	
Acarbose	 102.11	 124.47	 ‐21.89 94.41 7.54 75.88	 25.68
Crude	methanol	extract	 93.86	 109.12	 7.33 88.64 5.56 82.80	 11.78
Methylene	chloride	 106.13	 117.90	 ‐11.09 90.17 15.03 93.30	 12.08
Ethyl	acetate	 92.88	 100.50	 ‐8.20 72.70 21.72 77.30	 16.77
Butanol	 121.15	 129.11	 ‐6.75	 111.27	 8.15	 98.29	 18.86	




solvent	 mainly	 affect	 on	 the	 total	 content	 of	 extracted	
phenolics.	However,	the	separation	of	crude	flavonoid	fraction	
by	 the	method	 described	 by	 Reference	 [11]	 did	 not	 increase	
extracted	 total	 flavonoid	 content	 in	 crude	 flavonoid	 fraction	
which	 may	 due	 to	 polarity	 varying	 of	 flavonoids	 content,	






Table	 3	 showed	 identification	 and	 determination	 of	
flavonoids	and	other	phenolics	components	of	T.	stans	 leaves	
by	 HPLC.	 Twenty	 three	 compounds	 could	 be	 identified,	 the	
phenolic	 profile	 showed	 the	 presence	 of	 phenolic	 acid	
derivatives	 (gallic	acid,	pyrogallol,	protocatchuic,	 chlorogenic,	
p‐OH	 benzoic,	 vanillic,	 ferulic,	 isoferulic,	 caffeic	 acid,	 ellagic	
acid,	p‐coumaric,	3,4,5‐trimethoxy	cinnamic	acid	and	cinnamic	
acid,	 three	 flavonoid	 glycosides	 (rutin,	 naringin	 and	
quercitrin)	 and	 six	 free	 flavonoids	 (quercetin,	 kampferol,	
apigenin,	 hesperitin,	7‐OH	 flavones	 and	 catechin)	 in	 different	
concentrations.	 Rutin	 was	 the	 predominant	 phenolic	 (112.7	
mg/100	 g	 dry	 leaves)	 followed	 by	 ferulic,	 pyrogallol,	
rosemarinic,	 3,4,5‐methoxy	 cinnamic,	 naringin,	 chlorogenic,	
quercitrin	and	quercetin	(31.38,	29.00,	27.1,	21.56,	21.4,	17.04,	
16.6	 and	 14.0	 mg/100	 g	 dry	 leaves),	 respectively.	 The	
previously	mentioned	phenolics	of	T.	stans	leaves	with	high	or	
moderated	 concentrations	 were	 reported	 to	 have	 different	
biological	 activities	 such	 as	 anti‐hyperglycemic,	 antioxidant,	
antimicrobial,	 anti‐inflammatory,	 anti‐thrombosis,	 anti‐






different	 spots	 of	 T.	 stans	methanolic	 extract	 as	 well	 as	 all	
other	fractions	using	the	running	system	(ethyl	acetate:	formic	





fractions.	 On	 the	 opposite	 rutin	 was	 absent	 in	 methylene	
chloride	 fraction.	 From	 the	above	mentioned	 results,	 it	 could	








responsible	 for	 the	digestive	hydrolysis	of	 food	starch	and	so	
they	cause	an	increase	 in	blood	glucose	 level	after	a	personal	
meal.	 So	 in	 vitro	 experiment	 for	 antiα‐amylase	 activity	 was	
done	 to	 evaluate	 the	 effect	 of	 T.	 stans	methanolic	 extract	 as	
well	 as	 all	 other	 fractions	as	natural	 inhibitors	 for	α‐amylase	
activity	as	alternative	strategy	 in	the	control	of	blood	glucose	













that	 crude	 flavonoid	 rich	 fraction	 had	 the	 strongest	
postprandial	anti‐hyperglycemic	effect	in	starch	tolerance	test.	
It	 decreases	 the	 glycemic	 peak	 by	 22.54	 and	 30.87%	 after	 2	
and	4	hours	of	orally	administration	of	starch.	 In	other	word,	
our	 findings	 demonstrated	 that	 rutin	 rich	 crude	 flavonoid	
fraction	was	more	effective	to	decrease	starch	tolerance	curve.	
In	this	respect	[41]	stated	that	rutin	metabolites	are	capable	of	
inhibiting	 ‐glucosidase	 activity	 both	 in	 vivo	 and	 in	 vitro	







all	 diabetic	 groups	 significantly	 decreased	 with	 different	








Normal	 93.55 107.08f ‐	
Diabetic	rats	 299.67 287.33a ‐	
Diabetic	rats	+	Metformin	hydrochloride	(as	a	reference	drug) 311.11 198.27b 36.27	
Diabetic	rats	+	Crude	methanol	extract	 324.17 121.17e 62.60	
Diabetic	rats	+	Methylene	chloride	fraction	 322.86 127.81d,e 60.40	
Diabetic	rats	+	Ethyl	acetate	fraction	 288.54 135.87d 52.91	
Diabetic	rats	+	Butanol	fraction	 311.76	 134.37d	 56.89	
Diabetic	rats	+	Crude	flavonoids	fraction	 281.90	 149.68c	 46.90	
Least	Significant	Difference	(0.01)	 ‐	 12.2138	 ‐	





with	62.6%	reduction	 in	blood	glucose	 level	 followed	by	 rich	
alkaloids‐methylene	 chloride	 fraction	 60.41%.	 Blood	 glucose	
values	were	324.17	and	322.86	mg/dL	at	the	beginning	of	the	
experiment	and	significantly	decreased	 to	121.17	and	127.81	
mg/dL	 for	 the	 same	 groups	 at	 the	 end	 of	 the	 experiment,	
respectively.	 Administration	 of	 crude	 flavonoid	 fraction	 of	T.	







Our	 findings	 for	 the	 antidiabetic	 potency	 of	 T.	 stans	




flavonoids,	 alkaloids,	 saponins	 and	 terpenes.	 It	 could	 be	
suggested	that	these	biomolecules	synergistically	improve	the	
sensitivity	 of	 insulin	 receptor	 to	 insulin	 or	 stimulate	
pancreatic	β‐cells	 to	release	 insulin	which	may	 finally	 lead	to	
improvement	 of	 carbohydrate	 hydrolyzing	 enzymes	 towards	
the	re‐establishment	of	normal	blood	glucose	level.	
On	 the	other	hand,	high	antidiabetic	potency	achieved	by	
alkaloid	 rich	 preparations	 (crude	 methanol	 extract	 and	
methylene	 chloride	 fraction)	 of	T.	 stans	 in	 the	 present	 study	
were	different	 from	those	of	other	researchers	 ,	who	showed	
that	 four	 purified	 alkaloids	 from	 Tecoma	 stans	 including	
tecomine	 and	 tecostanine	 did	 not	 decrease	 glucose	 level	 of	
diabetic	 db/db	 mice	 [7,8].	 Here,	 again	 we	 suggest	 that	
tecomine	 and	 tecostanine	 alkaloids	 synergistically	 act	 with	
other	 bioactive	 molecules	 such	 as	 flavonoids	 in	 T.	 stans	 as	
hypoglycemic	agents.		
In	 the	 present	 investigation	 it	 was	 mentioned	 that	
flavonoid‐rich	fraction	decreased	fasting	blood	glucose	with	a	
percent	of	46.90	in	STZ	diabetic	rats	experiment.	This	finding	
disagreed	with	 reference	 [9]	 that	 showed	 that	 rich	phenolics	
aqueous	 extract	 of	 Tecoma	 stans	 reduces	 triglycerides	 and	
cholesterol,	without	modifying	fasting	glucose	in	STZ‐induced	
diabetic	 rats.	 This	 may	 due	 to	 the	 differences	 in	 phenolics	
content	between	the	examined	fractions.	Generally,	flavonoids	
exert	 their	hypoglycemic	effects	either	 through	 their	capacity	
to	 inhibit	glucose	absorption	or	 to	 increase	glucose	 tolerance	
[43].	In	this	respect,	rutin;	the	predominant	detected	flavonoid	
in	 the	 present	 study;	 was	 recently	 reported	 as	 a	 strong	
hypoglycemic	 agent	 since	 it	 decreased	 blood	 glucose	 level	 of	
diabetic	patients	[44].	The	mode	of	action	of	rutin	was	shown	
by	 several	 researchers.	 They	 stated	 that,	 it	 is	 a	 polyphenolic	
flavonoid,	 which	 could	 induce	 pancreatic	 β	 cells	 to	 produce	
insulin	 and	 or	 protect	 them	 from	 further	 deterioration	
[36,45,46].	 Although,	 flavonoids	 fraction	 positively	 affect	 on	
glucose	 level	 in	 STZ	 treated	 rats	 in	 the	 present	 study.	 The	
results	 showed	 that	 mother	 methanolic	 extract	 and	 their	
resultant	fractions	exert	more	hypoglycemic	effect	than	that	of	
the	 previously	 mentioned	 fraction.	 In	 other	 words,	 the	
previously	results	which	were	indicated	that	crude	flavonoids	
fraction	 were	 the	 most	 effective	 fraction	 as	 α‐amylase	
inhibitors	 in	 both	 in	 vivo	 and	 in	 vitro	 experiments	were	 not	
confirmed	 by	 their	 pattern	 in	 STZ‐treated	 rats.	 The	 present	
data	prove	 that	 flavonoids	 of	T.	 stans	 act	 synergistically	with	
other	 natural	 metabolites	 especially	 alkaloids	 as	 anti‐
hyperglycemic	agents	in	the	treatment	of	diabetes.	
Tables	6	and	7	showed	blood	lipid	profile	of	experimental	
animals.	 It	 could	 be	 noticed	 that	 diabetic	 rats	 showed	 a	
significant	 elevation	 of	 total	 cholesterol,	 triglycerides,	 VLDL‐
cholesterol	 and	 LDL‐cholesterol.	 Their	 values	 were	 103.37,	
162.14,	 32.42	 and	 40.4	 mg/dL,	 respectively,	 at	 the	 end	 of	
feeding	period.	Also,	diabetic	control	rats	showed	a	significant	
decrease	 in	 HDL‐cholesterol	 where	 their	 value	 was	 30.55	
mg/dL.	High	Atherogenic	Index	(AI)	2.38	was	recorded	for	the	
diabetic	rats	at	the	end	of	the	experiment.		
These	 findings	 agreed	 with	 those	 of	 reference	 [47],	 who	
mentioned	 that	 diabetes	 mellitus	 (especially	 Type	 1)	 is	
accompanied	 by	 hypercholesterolemia,	 hyperlipidemia	 and	
hepatic	steatosis.	 Insulin	deficiency	 in	diabetes	patients	 leads	
to	 abnormal	 metabolic	 processes;	 this	 in	 turn	 leads	 to	
accumulation	of	lipids	such	as	TG	and	TC	[48].		
Also,	 Suckling	 and	 Jackson	 [49]	 reported	 that	 insulin	
deficiency	will	 lead	 to	 decrease	 activity	 of	 lipoprotein	 lipase	
and	 increase	 free	 fatty	acids	mobilisation	 from	peripheral	 fat	
depots.	So,	 the	STZ‐induced	diabetic	rat	 is	 thus	considered	as	
an	 animal	 model	 of	 Type	 1	 diabetes	 mellitus	 and	 hyperlipi‐
demia.	
Total	 cholesterol	 content	 of	 diabetic	 rats	 treated	 by	 all	
plant	 extracts	 decreased	 significantly;	 comparing	 to	 diabetic	
untreated	 rats	 (Group	 2)	 at	 the	 end	 of	 feeding	 period.	
Moreover,	administration	of	oral	doses	of	methylene	chloride,	
crude	 methanol	 and	 ethyl	 acetate	 fractions	 to	 experimental	
animals	 for	 28	 days	 decreased	 total	 cholesterol	 to	 a	 non‐
significant	 value	 with	 normal	 rats,	 where	 their	 values	 were	
70.68,	71.44	and	72.72	mg/dL,	respectively.	
Concerning	 serum	 triglycerides,	 the	 lowest	 value	 was	
obtained	 when	 ethyl	 acetate	 fraction	 of	 T.	 stans	 daily	
administrated	 to	 diabetic	 rats	 for	 28	 day,	 it	 decreased	 to	 be	
60.91	 mg/dL.	 Treatment	 with	 other	 fractions	 of	 T.	 stans	






Groups	*	 Total	cholesterol	(mg/dL)	 Triglycerides	(mg/dL)	 	HDL‐c	(mg/dL)	
Normal	 73.58	d 50.83	g 45.98	a 
Diabetic	rats	 103.37	a 162.14	a 30.55	g	
Diabetic	rats	+	Metformin	hydrochloride	(as	a	reference	drug)	 91.79	b	 144.85	b	 34.15	e,f	
Diabetic	rats	+	Crude	methanol	extract	 71.44	d	 84.97	e	 35.02	d,e	
Diabetic	rats	+	Methylene	chloride	fraction	 70.68	d	 110.19	c	 32.77	f,g	
Diabetic	rats	+	Ethyl	acetate	fraction	 72.72	d	 60.91	f	 39.56	c	
Diabetic	rats	+	Butanol	fraction	 82.96	c 96.70d 37.90d	
Diabetic	rats	+	Crude	flavonoids	fraction	 86.78	c 84.27	e 42.13	b	
Least	Significant	Difference	(0.01)	 6.2665 10.4704 3.3379	





Groups	 VLDL‐c	(mg/dL)	 LDL‐c	(mg/dL)	 AI	(Atherogenic	index)	
Normal	 10.16	g 17.44	c,d 0.60	f	
Diabetic	rats	 32.42	a 40.40	a 2.38	a	
Diabetic	rats	+	Metformin	hydrochloride	(as	a	reference	drug) 28.97	b 38.67	b 1.68	b	
Diabetic	rats	+	Crude	methanol	extract	 16.99	e 19.43	c 1.03	d	
Diabetic	rats	+	Methylene	chloride	fraction	 22.03	c	 15.88	d	 1.15	c	
Diabetic	rats	+	Ethyl	acetate	fraction	 12.18	f	 20.98	c	 0.83	e	
Diabetic	rats	+	Butanol	fraction	 19.34	d	 25.72	b	 1.18	c	
Diabetic	rats	+	Crude	flavonoids	fraction	 16.85	e 27.80	b 1.05	d	
Least	Significant	Difference	(0.01)	 2.0941 4.4498 0.1337	




Groups	 Creatinine	(mg/dL)	 Uric	acid	(mg/dL)	 ALT	(U/L)	
Normal	 1.20	e 0.95	g 36.62	f	
Diabetic	rats	 3.14	a 4.65	a 66.50	a	
Diabetic	rats	+	Metformin	hydrochloride	(as	a	reference	drug) 2.55	b 3.24	b 49.80	b	
Diabetic	rats	+	Crude	methanol	extract	 1.70	c,d 1.89	c 41.85	d,e	
Diabetic	rats	+	Methylene	chloride	fraction	 1.80	c,d 1.71	d 43.65	c,d	
Diabetic	rats	+	Ethyl	acetate	fraction	 1.54	d	 1.25	e,f	 39.37	e,f	
Diabetic	rats	+	Butanol	fraction	 1.84	c	 1.47	e	 46.20	b,c	
Diabetic	rats	+	Crude	flavonoids	fraction	 1.87	c	 1.24	f,g	 43.66	d,e	
Least	Significant	Difference	(0.01)	 0.2711 0.3134 5.4390	




Similarly	 the	 lowest	 values	 for	 VLDL‐c	 and	 atherogenic	
index	 were	 obtained	 when	 ethyl	 acetate	 fraction	 of	 T.	 stans	
daily	administrated	to	diabetic	rats	for	28	day,	it	decreased	to	
be	12.18	and	0.83	mg/dL,	respectively.	Also,	other	fractions	of	
T.	 stans	 gave	 satisfied	 results	 for	 the	 same	 mentioned	
parameters.	
Lipid	 profile	 of	 animal	 groups	 treated	 with	 different	 T.	
stans	 preparations;	 especially	 ethyl	 acetate	 fraction;	 was	
relative	 to	 that	of	healthy	non	diabetic	 rats.	 It	was	 clear	 that	
ethyl	 acetate	 fraction;	 the	 most	 successful	 fraction	 in	
controlling	 lipid	 profile	 of	 diabetic	 rats;	 had	 the	 highest	
amount	 of	 flavonoids	 as	 (59.91	 mg	 as	 quercetin	 equiva‐
lents/g).	 Therefore,	 it	 could	 be	 suggested	 that	 the	 positive	
effects	of	different	preparations	of	T.	stans	 in	controlling	lipid	
profile	might	 due	 to	 the	 presence	 of	 considerable	 amount	 of	






stans	 leaves.	Moreover,	different	 preparations	of	T.	 stans	 had	
high	polyphenols	content	which	ranged	from	102.49	to	279.41	
as	 gallic	 acid/g	 dry	 extract.	 Therefore,	 it	was	 suggested	 that,	
total	 polyphenols	 content	 of	 T.	 stans	 especially,	 ferulic	 acid	
may	contribute	the	anti‐hyperlipidemic	action	in	diabetic	rats.	
These	 findings	 agreed	 with	 those	 of	 reference	 [52]	 who	
showed	that	ferulic	acid	was	able	to	decreased	abnormal	lipid	
levels	 (i.e.	 free	 fatty	 acids,	 cholesterol,	 triglycerides	 and	
phospholipids)	of	nicotine‐induced	tissue	damage	rats.	
Table	8	summarizes	the	concentration	of	serum	creatinine,	




feeding	 period.	 When	 different	 extracts	 of	 T.	 stans	 were	
administered	to	rats,	the	above	parameters	were	significantly	
decreased	 with	 the	 superior	 of	 ethyl	 acetate	 fraction	 which	
their	 values	 were	 1.54,	 1.25	 mg/dL	 and	 39.37	 U/L,	 respect‐
tively.	
Table	 9	 showed	 the	 effect	 of	 T.	 stans	 leaves	 extracts	 on	
liver	malondialdehyde	 (MDA)	and	 reduced	glutathione	 (GSH)	
levels.	It	could	be	observed	that,	MDA	level	as	an	index	of	lipid	
peroxidation,	significantly	increased	in	livers	of	streptozotocin	
diabetic	 animals	 (Group2;	 42.14nmole	 of	 MDA	 /g	 tissue)	 as	
compared	 to	 healthy	 rats	 (Group1;	 18.77	 nmole	 of	 MDA	 /g	
tissue).	Oxygen	 free	 radicals	 intensively	 increased	 in	diabetic	
animals	 due	 to	 impaired	 glucose	metabolism,	which	 leads	 to	
oxidative	stress	as	mentioned	by	Ceriello	et	al.	[53].	Treatment	
with	 different	 preparations	 of	T.	 stans	 resulted	 in	 significant	
decrease	 in	 liver	 tissue	 MDA.	 The	 lowest	 value	 of	 MDA	was	
achieved	when	 rats	 treated	 orally	with	 the	mother	methanol	
extract	(25.11	nmole/g	tissue).	
It	 was	 observed	 that	 GSH	 level;	 which	 protect	 the	 body	
cells	 against	 toxic	 effects	 of	 lipid	 peroxidation;	 was	
significantly	depleted	in	liver	tissue	of	diabetic	control	animals	
(Group	2;	22.42	μmole/g	 tissue)	as	 compared	 to	healthy	 rats	
(Group	 1;	 50.5	 μmole/g	 tissue).	 Treatments	 with	 T.	 stans	
different	 preparations	 for	 28	 days	 resulted	 in	 significant	
increase	 in	 liver	 tissue	 GSH.	 Its	 values	 were	 46.22,	 38.22,	
45.54,	 40.13and	 41.11	 μmole/g	 tissue,	 for	 groups	 of	 rats	
treated	 with	 methanol,	 methylene	 chloride,	 ethyl	 acetate,	
butanol	and	flavonoids	fractions,	respectively.	
In	the	current	study,	high	polyphenolic	contents	(Table	2)	
of	T.	 stans	 preparations	which	 ranged	 from	102.49	 to	279.41	





















In	 this	 respect,	 Pietta	 [54]	 showed	 that	 the	 antioxidant	
activity	of	the	polyphenolic	flavonoids	may	due	to	their	ability	
to	neutralize	the	free	radicals	and	reduce	their	formation.	The	
same	 author	 added	 that	 most	 digested	 flavonoids	 are	
extensively	degraded	to	various	phenolic	acids,	some	of	which	
still	 possess	 a	 radical‐scavenging	 ability.	 Both	 the	 absorbed	





In	 conclusion,	 all	 preparations	 of	 T.	 stans	 are	 able	 to	
exhibit	 positive	 effects	 as	 antihyperglycemic,	 anti‐hyperlipi‐
demic,	 hepatorenal	 protective	 and	 antioxidant	 roles	 with	
different	 extents.	 Crude	 flavonoids	 had	 the	 strongest	 post‐
prandial	antihyperglycemic	effect	 in	starch	tolerance	curve	in	
normal	rats.	The	concentration	of	crude	flavonoids	which	give	
50%	 inhibition	 of	 α‐amylase	was	 the	 lowest	 between	 all	 the	
preparations	 of	T.	 stans.	 All	 examined	 fractions	 of	T.	 stans	 in	
the	present	study	were	able	to	decrease	fasting	blood	glucose	
significantly	 with	 different	 extends	 in	 STZ	 sub‐chronic	
experiment.	The	maximum	effect	was	detected	when	rats	were	
treated	 with	 rich	 alkaloids	 fractions	 (methanolic	 and	
methylene	chloride	 fraction).	The	present	study	suggests	that	
alkaloids	 synergistically	 act	 with	 other	 phytomolecules	
especially	 flavonoids	as	 anti‐hyperglycemic	 agents.	Generally,	
the	 anti‐diabetic	 effect	 of	 T.	 stans	 is	 due	 to	 intestinal	 α‐
glucosidase	 inhibition	 by	 decreasing	 the	 postprandial	 hyper‐
glycaemia	 peak,	 in	 addition	 to	 modifying	 fasting	 glucose.	
Finally	 ethyl	 acetate	 fraction	 exhibits	 the	 most	 desirable	
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